UCB - Equity Capital And Reserves



UCB reported EUR10.03B in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Alcon AG USD 22.13B 111M Jun/2025
Almirall EUR 1.46B 37.19M Jun/2025
Amarin USD 473.69M 12.49M Mar/2025
argenx SE 6.1B 597.47M Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Galapagos EUR 2.64B 104.07M Jun/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GRIFOLS EUR 7.6B 1.96B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.26B 1.64B Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Orion EUR 919.6M 147.2M Jun/2025
Recordati EUR 1.87B 107.18M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
UCB EUR 10.03B 1.08B Dec/2024
Unibail Rodamco EUR 17.67B 2.91B Dec/2024